# Warner Chilcott clinical trials: 58 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 58 trials with Warner Chilcott as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Warner Chilcott: 58 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/warner-chilcott

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 58
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 58, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| February 2, 2016 | NCT02670785 | A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy | Warner Chilcott | Phase 2 | Completed | Vulvovaginal Atrophy, Menopause, Dyspareunia | 203 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02670785) |
| September 11, 2013 | NCT01939184 | Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia | Warner Chilcott | Phase 2 | Completed | Benign Prostatic Hyperplasia | 796 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01939184) |
| May 3, 2013 | NCT01845649 | Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia | Warner Chilcott | Phase 3 | Completed | Vulvovaginal Atrophy | 550 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01845649) |
| March 21, 2013 | NCT01816139 | Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women | Warner Chilcott | Phase 3 | Completed | Vulvovaginal Atrophy | 576 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01816139) |
| March 13, 2013 | NCT01810575 | Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction | Warner Chilcott | Phase 2 | Terminated | Erectile Dysfunction | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01810575) |
| October 20, 2011 | NCT01455597 | Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream) | Warner Chilcott | Phase 3 | Completed | Vulvovaginal Atrophy | 309 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01455597) |
| July 22, 2011 | NCT01400776 | Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women | Warner Chilcott | Phase 3 | Completed | Postmenopausal Vulvovaginal Atrophy | 722 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01400776) |
| November 29, 2010 | NCT01249261 | Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover | Warner Chilcott | Phase 3 | Completed | Postmenopausal Women With Osteoporosis | 61 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01249261) |
| October 29, 2010 | NCT01230541 | Effect of Udenafil on Spermatogenesis | Warner Chilcott | Phase 1 | Completed | Spermatogenesis, Erectile Dysfunction | 239 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01230541) |
| April 30, 2010 | NCT01113931 | Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin | Warner Chilcott | Phase 3 | Completed | Urogential Chlamydia Trachomatis Infection | 495 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01113931) |
| February 18, 2010 | NCT01070979 | Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms. | Warner Chilcott | Phase 3 | Completed | Hormone Replacement Therapy | 249 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01070979) |
| February 9, 2010 | NCT01065012 | Treatment of Erectile Dysfunction - Long Term Safety and Efficacy | Warner Chilcott | Phase 3 | Completed | Erectile Dysfunction | 1,027 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01065012) |
| December 22, 2009 | NCT01037244 | Treatment of Erectile Dysfunction I | Warner Chilcott | Phase 3 | Completed | Erectile Dysfunction | 618 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01037244) |
| December 22, 2009 | NCT01037218 | Treatment of Erectile Dysfunction II | Warner Chilcott | Phase 3 | Completed | Erectile Dysfunction | 601 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01037218) |
| October 29, 2009 | NCT01004185 | Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative... | Warner Chilcott | Phase 3 | Terminated | Ulcerative Colitis | 39 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01004185) |
| August 12, 2009 | NCT00957034 | Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure | Warner Chilcott | Phase 2 | Terminated | Heart Failure | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00957034) |
| July 3, 2009 | NCT00932321 | Study of Safety and Efficacy of an Oral Contraceptive | Warner Chilcott | Phase 3 | Completed | Prevention of Pregnancy | 938 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00932321) |
| June 11, 2009 | NCT00918749 | Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women | Warner Chilcott | Phase 2 | Completed | Postmenopausal Osteoporosis | 205 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00918749) |
| March 25, 2009 | NCT00868907 | Study Assessing Dosing Time and Calcium and Vitamin D on the Relative BA of 35 mg DR Risedronate Dosed With Food | Warner Chilcott | Phase 1 | Completed | Healthy | 101 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00868907) |
| February 18, 2009 | NCT00846196 | A Study to Assess the Bioequivalence of Different Formulations of Risedronate in Healthy Male and Female Subjects | Warner Chilcott | Phase 1 | Completed | Osteoporosis | 538 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00846196) |
| February 5, 2009 | NCT00837746 | Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate | Warner Chilcott | Observational | Completed | Osteoporosis | 29 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00837746) |
| November 17, 2008 | NCT00791856 | Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch | Warner Chilcott | Phase 1 | Completed | Healthy | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00791856) |
| October 27, 2008 | NCT00780507 | Fecal Biomarker Study for Patients With Ulcerative Colitis | Warner Chilcott | Observational | Completed | Ulcerative Colitis | 89 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00780507) |
| October 23, 2008 | NCT00778154 | Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate | Warner Chilcott | Observational | Completed | Postmenopausal Osteoporosis | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00778154) |
| September 19, 2008 | NCT00755872 | Assess the Influence of a High-fat Meal on the Relative Bioavailability Of Two Formulations of Risedronate | Warner Chilcott | Phase 1 | Completed | Bioavailability | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00755872) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 10 |
| Phase 2 | 11 |
| Phase 3 | 32 |
| Phase 4 | 2 |
| Observational | 3 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 52 |
| Terminated | 6 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Colitis, Ulcerative | 8 |
| Osteoporosis | 7 |
| Sexual Dysfunctions, Psychological | 7 |
| Erectile Dysfunction | 5 |
| Osteoporosis, Postmenopausal | 5 |
| Dyspareunia | 2 |
| Bone Diseases, Metabolic | 2 |
| Acne Vulgaris | 2 |
| Urinary Bladder, Overactive | 1 |
| Meningomyelocele | 1 |
| Spinal Cord Injuries | 1 |
| Diverticulitis | 1 |
| Prostatic Hyperplasia | 1 |
| Heart Failure | 1 |
| Inflammatory Bowel Diseases | 1 |
| Chlamydia Infections | 1 |
| Osteogenesis Imperfecta | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Garage door companies in the United States](https://specstream.ai/data/businesses/garage-door-companies/united-states)
- [Software development companies in the United States](https://specstream.ai/data/businesses/software-development-companies/united-states)
- [Dental laboratories in the United States](https://specstream.ai/data/businesses/dental-laboratories/united-states)
- [Personal injury law firms in the United States](https://specstream.ai/data/businesses/personal-injury-law-firms/united-states)
- [Biotechnology companies in the United States](https://specstream.ai/data/businesses/biotechnology-companies/united-states)
- [Live and raw food restaurants in the United States](https://specstream.ai/data/businesses/live-and-raw-food-restaurants/united-states)
